Clinical trialNCT00314210CompletedPhase 3Interventional

Safety and Efficacy Maintenance Study of Quetiapine SR to Treat GAD Patients.

SponsorAstraZenecaEnrollment575Anxiety Disorders

View the registry record on ClinicalTrials.gov

Summary

The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

Martin Brecher, MD
AstraZeneca
Study Director
clinicaltrials.gov ↗

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

114 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Australia

Research Site
Brisbane, Queensland, Australia
Research Site
Everton Park, Queensland, Australia
Research Site
West Burleigh, Queensland, Australia
Research Site
Malvern, Victoria, Australia
Research Site
Prahran, Victoria, Australia

Canada

Research Site
Edmonton, Alberta, Canada
Research Site
Bathurst, New Brunswick, Canada
Research Site
Hamilton, Ontario, Canada
Research Site
Kingston, Ontario, Canada
Research Site
Orléans, Ontario, Canada
Research Site
Toronto, Ontario, Canada
Research Site
Waterloo, Ontario, Canada
Research Site
Gatineau, Quebec, Canada
Research Site
Montreal, Quebec, Canada

Finland

Research Site
Helsinki, Finland
Research Site
Joensuu, Finland
Research Site
Kuopio, Finland
Research Site
Oulu, Finland
Research Site
Pori, Finland
Research Site
Seinäjoki, Finland
Research Site
Turku, Finland

Germany

Research Site
Berlin, Germany
Research Site
Göttingen, Germany
Research Site
Jena, Germany
Research Site
Leipzig, Germany
Research Site
München, Germany
Research Site
Naumburg, Germany
Research Site
Nuremberg, Germany
Research Site
Schwerin, Germany
Research Site
Siegen, Germany

Hungary

Research Site
Balassagyarmat, Hungary
Research Site
Budapest, Hungary
Research Site
Gyula, Hungary
Research Site
Győr, Hungary
Research Site
Kecskemét, Hungary
Research Site
Nyíregyháza, Hungary

Indonesia

Research Site
Bandung, West Java, Indonesia
Research Site
Jakarta, Indonesia

Philippines

Research Site
Cebu City, Philippines
Research Site
Davao City, Philippines

74 more sites on the registry record.ClinicalTrials.gov ↗

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start: 31 Mar 2006
Primary completion: —
Completion: 31 Aug 2007
Last update posted: 25 Mar 2009
Registered enrollment: 575
Registry id: NCT00314210

clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.